Informations sur le nombre total de droits de vote et d'actions
September 27, 2024 02:05 ET
|
Nyxoah
INFORMATION RÉGLEMENTÉE Informations sur le nombre total de droits de vote et d'actions Mont-Saint-Guibert (Belgique), le 27 septembre 2024, 8:05 CET / 2:05h ET – Conformément à l'article 15 de la...
Information on the total number of voting rights and shares
September 27, 2024 02:05 ET
|
Nyxoah
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), September 27, 2024, 08:05 am CET / 2:05 am ET – In accordance with article 15 of the...
Publication relative à des notifications de transparence
September 27, 2024 02:00 ET
|
Nyxoah
INFORMATION RÉGLEMENTÉE Publication relative à des notifications de transparence Mont-Saint-Guibert (Belgique), le 27 septembre 2024, 08:00h CET / 2:00h ET – Conformément à l'article 14 de la...
Publication relating to transparency notifications
September 27, 2024 02:00 ET
|
Nyxoah
REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), September 27, 2024, 8.00am CET / 2.00am ET – In accordance with article 14 of...
VEON Bonds to Re-Enter CEMBI and JACI Indices
September 27, 2024 01:30 ET
|
VEON Ltd.
Amsterdam, 27 September 2024 – VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces that the VEON Holdings...
Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024
September 27, 2024 01:00 ET
|
Molecular Partners
First RDT candidate MP0712 shows low kidney accumulation and high tumor uptake in preclinical models MP0712 treatment leads to strong tumor growth inhibition with a good safety profile in vivo ...
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
September 26, 2024 23:26 ET
|
Cue Biopharma, Inc.
BOSTON, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and...
ハット8 (Hut 8)、GPUaaS (GPU-as-a-Service) を初導入し、稼働開始
September 26, 2024 22:24 ET
|
Hut 8 Corp.
マイアミ発, Sept. 27, 2024 (GLOBE NEWSWIRE) -- 大規模エネルギーインフラストラクチャの大手垂直統合オペレーターであり、北米最大のビットコイン・マイナーの1つであるハット8コーポレーション (Hut 8 Corp.) (NASDAQ | TSX: HUT) (「ハット8」または「同社」)...
Banzai Announces Closing of $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
September 26, 2024 19:30 ET
|
Banzai International, Inc.
Banzai Announces Closing of $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Provident Financial Holdings Announces Extension of September 2023 Stock Repurchase Plan
September 26, 2024 18:57 ET
|
Provident Financial Holdings, Inc.
RIVERSIDE, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B., today announced that...